Selenium and inflammation : potential use and future perspectives

2015
journal article
article
12
dc.abstract.enThe essential trace element selenium (Se) is constitutively incorporated as selenocysteine, in proteins, among others in antioxidative selenoproteins, such as glutathione peroxidase(s) and thioredoxin reductase. Since chronic inflammation is thought to deplete Se stores in the body, Se supplementation should be considered in prolonged inflammatory states, Se being the trace element the most affected in chronic or low-grade inflammation. Se administration might also be beneficial in bacterial and viral diseases as well as metabolic and autoimmune diseases. In order to maintain a Se steady state, or "selenostasis", Se supplementation, via either diet or compounds, is required to preserve the activity of selenoproteins in antioxidative and redox processes. Importantly, Se could play a pivotal role in the maintenance of homeostasis in infected tissues by inhibiting the proinflammatory toll-like receptor nuclear factor kappa-light-chain-enhancer of activated B cells signaling pathway and counteracting proinflammatory cytokine action. Finally, while Se status shows considerable promise as a valid marker of inflammatory and autoimmune disease, new functional Se nanoparticles and highly bioavailable selenomethionine compounds will in all probability provide a more efficacious and reliable intervention tool in both preventive and therapeutic disease management.pl
dc.affiliationWydział Lekarski : Klinika Endokrynologiipl
dc.cm.date2020-01-07
dc.cm.id74732
dc.contributor.authorDuntas, Leonidas H.pl
dc.contributor.authorHubalewska-Dydejczyk, Alicja - 129732 pl
dc.date.accessioned2020-01-17T08:58:56Z
dc.date.available2020-01-17T08:58:56Z
dc.date.issued2015pl
dc.date.openaccess0
dc.description.accesstimew momencie opublikowania
dc.description.number2pl
dc.description.physical97-102pl
dc.description.points5pl
dc.description.publication1pl
dc.description.versionostateczna wersja wydawcy
dc.description.volume11pl
dc.identifier.doi10.17925/USE.2015.11.02.97pl
dc.identifier.eissn1758-3926
dc.identifier.issn1758-3918pl
dc.identifier.projectROD UJ / OPpl
dc.identifier.urihttps://ruj.uj.edu.pl/xmlui/handle/item/136531
dc.languageengpl
dc.language.containerengpl
dc.rightsUdzielam licencji. Uznanie autorstwa - Użycie niekomercyjne
dc.rights.licenceCC-BY-NC
dc.rights.simpleviewWolny dostęp
dc.rights.urihttp://creativecommons.org/licenses
dc.share.typeinne
dc.subject.enseleniumpl
dc.subject.eninflammationpl
dc.subject.englutathione peroxidasespl
dc.subject.enthioredoxin reductasepl
dc.subject.enhuman immunodeficiency viruspl
dc.subtypeArticlepl
dc.titleSelenium and inflammation : potential use and future perspectivespl
dc.title.journalUS Endocrinologypl
dc.typeJournalArticlepl
dspace.entity.typePublication
dc.abstract.enpl
The essential trace element selenium (Se) is constitutively incorporated as selenocysteine, in proteins, among others in antioxidative selenoproteins, such as glutathione peroxidase(s) and thioredoxin reductase. Since chronic inflammation is thought to deplete Se stores in the body, Se supplementation should be considered in prolonged inflammatory states, Se being the trace element the most affected in chronic or low-grade inflammation. Se administration might also be beneficial in bacterial and viral diseases as well as metabolic and autoimmune diseases. In order to maintain a Se steady state, or "selenostasis", Se supplementation, via either diet or compounds, is required to preserve the activity of selenoproteins in antioxidative and redox processes. Importantly, Se could play a pivotal role in the maintenance of homeostasis in infected tissues by inhibiting the proinflammatory toll-like receptor nuclear factor kappa-light-chain-enhancer of activated B cells signaling pathway and counteracting proinflammatory cytokine action. Finally, while Se status shows considerable promise as a valid marker of inflammatory and autoimmune disease, new functional Se nanoparticles and highly bioavailable selenomethionine compounds will in all probability provide a more efficacious and reliable intervention tool in both preventive and therapeutic disease management.
dc.affiliationpl
Wydział Lekarski : Klinika Endokrynologii
dc.cm.date
2020-01-07
dc.cm.id
74732
dc.contributor.authorpl
Duntas, Leonidas H.
dc.contributor.authorpl
Hubalewska-Dydejczyk, Alicja - 129732
dc.date.accessioned
2020-01-17T08:58:56Z
dc.date.available
2020-01-17T08:58:56Z
dc.date.issuedpl
2015
dc.date.openaccess
0
dc.description.accesstime
w momencie opublikowania
dc.description.numberpl
2
dc.description.physicalpl
97-102
dc.description.pointspl
5
dc.description.publicationpl
1
dc.description.version
ostateczna wersja wydawcy
dc.description.volumepl
11
dc.identifier.doipl
10.17925/USE.2015.11.02.97
dc.identifier.eissn
1758-3926
dc.identifier.issnpl
1758-3918
dc.identifier.projectpl
ROD UJ / OP
dc.identifier.uri
https://ruj.uj.edu.pl/xmlui/handle/item/136531
dc.languagepl
eng
dc.language.containerpl
eng
dc.rights
Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne
dc.rights.licence
CC-BY-NC
dc.rights.simpleview
Wolny dostęp
dc.rights.uri
http://creativecommons.org/licenses
dc.share.type
inne
dc.subject.enpl
selenium
dc.subject.enpl
inflammation
dc.subject.enpl
glutathione peroxidases
dc.subject.enpl
thioredoxin reductase
dc.subject.enpl
human immunodeficiency virus
dc.subtypepl
Article
dc.titlepl
Selenium and inflammation : potential use and future perspectives
dc.title.journalpl
US Endocrinology
dc.typepl
JournalArticle
dspace.entity.type
Publication
Affiliations

* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.

Views
93
Views per month
Views per city
Christchurch
15
Brisbane
4
Guangzhou
3
Krakow
3
Ashburn
2
Bang Phlat
2
Dasha
2
Des Moines
2
Dublin
2
Odense
2
Downloads
hubalewska-dydejczyk_duntas_selenium_and_inflammation_2015.pdf
41
hubalewska-dydejczyk_duntas_selenium_and_inflammation_2015.odt
2